# Personalization of AntiTB Treatment: Evaluation of Pharmacological Determinants of Treatment Response

> **NCT03416309** · — · UNKNOWN · sponsor: **University of Turin, Italy** · enrollment: 257 (estimated)

## Conditions studied

- Tuberculosis, Pulmonary

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03416309
- **Lead sponsor:** University of Turin, Italy
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-25
- **Primary completion:** 2021-02-28
- **Final completion:** 2022-02-28
- **Target enrollment:** 257 (ESTIMATED)
- **Last updated:** 2019-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03416309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03416309, "Personalization of AntiTB Treatment: Evaluation of Pharmacological Determinants of Treatment Response". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03416309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*